R Hovorka - Diabetic medicine, 2006 - duke.edu Background The last two decades have witnessed unprecedented technological
progress in the development of continuous glucose sensors, resulting in the
first generation of commercial glucose monitors. This has fuelled the ... Cited by 113 - Related articles - View as HTML - BL Direct - All 7 versions
J Plank, A Siebenhofer, A Berghold, K Jeitler, … - Archives of Internal Medicine, 2005 - Am Med Assoc Results Forty-two randomized controlled trials that assessed the effect of SAI
analogues vs regular insulin in 7933 patients with type 1 diabetes mellitus,
type 2 diabetes mellitus, and gestational diabetes mellitus were ... Cited by 78 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org C Homko, A Deluzio, C Jimenez, JW … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Seven C-peptide–negative patients with type 1
diabetes (two men and five women) were studied at the General Clinical Research
Center at Temple University Hospital two times, 1 month apart. Their plasma ... Cited by 65 - Related articles - BL Direct - All 6 versions
T Danne, J Aman, E Schober, D Deiss, JL … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—Glycemic control for postprandial treatment was not worse than
preprandial treatment as assessed by fructosamine week 0 vs. 6 (mean ± SD,
preprandial 367 ± 74 vs. 378 ± 90 μmol/l; postprandial 383 ± 83 vs. 385 ... Cited by 61 - Related articles - BL Direct - All 7 versions
- ►adisonline.com [PDF] R Oiknine, M Bernbaum, AD Mooradian - Drugs, 2005 - pt.wkhealth.com Insulin is one of the oldest and best studied treatments for diabetes mellitus.
Despite many improvements in the management of diabetes, the nonphysiological
time-action profiles of conventional insulins remain a significant ... Cited by 59 - Related articles - All 5 versions
A Siebenhofer, J Plank, A Berghold, K Horvath … - Diabetologia, 2004 - Springer Aims/hypothesis. This study aimed to compare the ef- fect of treatment with
short-acting insulin (SAI) ana- logues versus structurally unchanged
short-acting in- sulin (regular insulin) on glycaemic control and on the ... Cited by 38 - Related articles - All 4 versions
G Dailey - Clinical therapeutics, 2004 - Elsevier Results: Large-scale intervention trials, such as the United Kingdom Prospective
Diabetes Study (UKPDS), have reported that patients with type 2 DM treated with
oral combination therapy are unable to maintain glycemic control. These ... Cited by 34 - Related articles - All 4 versions
AJ Garber, R Ligthelm, JS Christiansen, A … - Diabetes Obesity and Metabolism, 2007 - interscience.wiley.com The progressive nature of type 2 diabetes makes insulin initiation a necessary
therapeutic step for many patients. Premixed insulin formulations containing
both basal and prandial insulin (so called biphasic insulin) are often ... Cited by 20 - Related articles - BL Direct - All 3 versions
T Heise, L Nosek, H Spitzer, L Heinemann, E … - Diabetes Obes Metab, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 13 - Related articles - All 2 versions
K Gamson, S Chia, L Jovanovic - Journal of Maternal-Fetal and Neonatal Medicine, 2004 - informahealthcare.com Diabetes during pregnancy is accompanied by increasing needs for maternal
insulin and ongoing biological changes that cause maternal insulin requirements
to reach higher and lower extremes throughout the day than in non-pregnant ... Cited by 12 - Related articles - BL Direct - All 6 versions
